Héritas to distribute VarSome Clinical in Argentina

Posted by Tomas Kucera on Jul 3, 2019 12:03:10 PM

Lausanne, Switzerland – July 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Héritas SA, an Argentinian precision-medicine company. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Héritas’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

VarSome and Swift Biosciences announce partnership to standardize and accelerate data interpretation for targeted NGS panels

Posted by Tomas Kucera on Jun 12, 2019 11:45:01 PM

Lausanne, June 12th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.

Molecular Vision Laboratory implements VarSome Clinical in its diagnostic workflow

Posted by Tomas Kucera on May 21, 2019 4:28:06 PM

Lausanne, May 21th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of advanced bioinformatics solutions, announced today a partnership with Molecular Vision Laboratory (MVL), a CAP and CLIA-certified medical diagnostic laboratory based in Oregon, USA, providing comprehensive genetic NGS-based testing for inherited retinal dystrophies.

Saphetor Portal became VarSome Clinical!

Posted by Tomas Kucera on Feb 4, 2019 1:21:22 PM

The Saphetor Portal has been updated to version 7 as of February 2nd 2019 under the new name VarSome Clinical. There are many changes since version 6, and this release brings our clinical platform up to date with the features, databases and classification visible in the free VarSome.com. Our clinical platform has been on the market since 2015 and is already being used by dozens of institutional clients, such as diagnostic laboratories, hospitals, and universities from countries all over the world.

Dr. Erik Zmuda becomes a member of VarSome's Advisory Board

Posted by Tomas Kucera on Nov 26, 2018 11:04:29 AM

Banner - LI 1 - Nov

Lausanne, Switzerland - November 26, 2018 - Saphetor SA, a Swiss precision medicine company and a leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing, announced today that Dr. Erik Zmuda has become a member of its Advisory Board.

HPST to distribute VarSome Clinical in the Czech Republic

Posted by Tomas Kucera on Nov 20, 2018 11:37:31 AM

Lausanne, Switzerland - November 20, 2018 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a partnership with HPST, s.r.o., an authorized distributor of Agilent Technologies for the Czech Republic. Saphetor’s clinically-certified platform for fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels extends HPST portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.